Literature DB >> 28759738

ABCB1 3435C>T and 2677G>T/A polymorphisms in Polish and Bosnian patients with Crohn's disease - A preliminary report.

Krzysztof Borecki1, Iwona Zawada, Anna Pawinska-Matecka, Nermin Nusret Salkic, Beata Karakiewicz, Grażyna Adler.   

Abstract

The role of ABCB1 single nucleotide polymorphisms (SNPs) in the development of Crohn's disease (CD) remains unclear. Due to inconsistent results of several European population-based studies and limited information on populations from Poland and Bosnia and Herzegovina (B&H), we conducted a preliminary association study of two main ABCB1 SNPs and CD. ABCB1 3435C>T and 2677G>T/A SNPs were analyzed in Polish and Bosnian patients with CD (n = 85 and n = 30, respectively) and controls (n = 82 and n = 30, respectively) using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) for 3435C>T and allele-specific PCR for 2677G>A/T SNP. A deviation from Hardy-Weinberg equilibrium was found for both SNPs in Polish patients with CD, and for 2677G>A/T in Polish control group. The allele and genotype frequencies of the two ABCB1 SNPs were not significantly different between the CD patients and controls in both populations (p > 0.05). Similarly, the genotype distribution of 3435C>T and 2677G>T/A SNPs was not significantly different between Polish and Bosnian patients with CD (p > 0.05). At least one mutated ABCB1 allele was carried by 97.7% of Polish and 90.0% of Bosnian patients with CD. No association was found between the ABCB1 SNPs and CD in the two populations. In conclusion, the two ABCB1 SNPs may not contribute to CD susceptibility in the populations of Poland and B&H. Further studies with larger samples in both populations are warranted.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28759738      PMCID: PMC5708903          DOI: 10.17305/bjbms.2017.2172

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  26 in total

1.  MDR1 gene polymorphism in ulcerative colitis.

Authors:  Jürgen Glas; Helga-Paula Török; Uwe Schiemann; Christian Folwaczny
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

2.  Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study.

Authors:  Clive M Onnie; Sheila A Fisher; Reenal Pattni; Jeremy Sanderson; Alastair Forbes; Cathryn M Lewis; Christopher G Mathew
Journal:  Inflamm Bowel Dis       Date:  2006-04       Impact factor: 5.325

3.  Association between the C3435T polymorphism of the MDR1 gene and Crohn's disease.

Authors:  Simon Lal; Joanne M Stempak; Christine Law; Abdul A Elkadri; A Hillary Steinhart; Mark S Silverberg
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

4.  MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis.

Authors:  Jun Wang; Xufeng Guo; Shijie Yu; Jixiang Zhang; Jia Song; Mengyao Ji; Zhuo Cao; Jing Wang; Ya Liu; Weiguo Dong
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

5.  Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease.

Authors:  S Ardizzone; G Maconi; V Bianchi; A Russo; E Colombo; A Cassinotti; C Penati; M L Tenchini; G Bianchi Porro
Journal:  Inflamm Bowel Dis       Date:  2007-05       Impact factor: 5.325

6.  Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?

Authors:  Ewa Jaźwińska-Tarnawska; Izabela Jęśkowiak; Ewa Waszczuk; Agata Mulak; Krystyna Głowacka; Magdalena Hurkacz; Leszek Paradowski; Zofia Zaleska; Anna Wiela-Hojeńska
Journal:  Pharmacol Rep       Date:  2014-10-18       Impact factor: 3.024

7.  Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease.

Authors:  T Fiedler; C Büning; W Reuter; G Pitre; E Gentz; H H Schmidt; J Büttner; J Ockenga; T Gerloff; C Meisel; H Lochs; I Roots; K Köpke; A Johne
Journal:  Eur J Clin Pharmacol       Date:  2007-07-31       Impact factor: 2.953

Review 8.  Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets.

Authors:  Vipul Yadav; Felipe Varum; Roberto Bravo; Esther Furrer; Daniela Bojic; Abdul W Basit
Journal:  Transl Res       Date:  2016-05-06       Impact factor: 7.012

9.  ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.

Authors:  Simon Fischer; Peter Laszlo Lakatos; Laszlo Lakatos; Agota Kovacs; Tamas Molnar; Istvan Altorjay; Maria Papp; Aniko Szilvasi; Zsolt Tulassay; Janos Osztovits; Janos Papp; Pal Demeter; Richard Schwab; Attila Tordai; Hajnalka Andrikovics
Journal:  Scand J Gastroenterol       Date:  2007-06       Impact factor: 2.423

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.